DK400884A - Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden - Google Patents
Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden Download PDFInfo
- Publication number
- DK400884A DK400884A DK400884A DK400884A DK400884A DK 400884 A DK400884 A DK 400884A DK 400884 A DK400884 A DK 400884A DK 400884 A DK400884 A DK 400884A DK 400884 A DK400884 A DK 400884A
- Authority
- DK
- Denmark
- Prior art keywords
- octahydropyrazolo
- quinolines
- tautomer
- alkylated
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53551983A | 1983-09-26 | 1983-09-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK400884D0 DK400884D0 (da) | 1984-08-22 |
DK400884A true DK400884A (da) | 1985-03-27 |
Family
ID=24134591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK400884A DK400884A (da) | 1983-09-26 | 1984-08-22 | Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0145121B1 (ko) |
JP (4) | JPS6110583A (ko) |
KR (1) | KR870001159B1 (ko) |
CA (1) | CA1270488A (ko) |
DE (1) | DE3484925D1 (ko) |
DK (1) | DK400884A (ko) |
GB (1) | GB2146984B (ko) |
GR (1) | GR80200B (ko) |
HU (1) | HU199836B (ko) |
IL (1) | IL72729A (ko) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6392722A (ja) * | 1986-10-03 | 1988-04-23 | Unitika Ltd | 熱接着繊維およびその不織布 |
JPS6392723A (ja) * | 1986-10-06 | 1988-04-23 | Unitika Ltd | 湿潤性複合繊維およびその不織布 |
JPS6420322A (en) * | 1987-07-13 | 1989-01-24 | Mitsubishi Petrochemical Co | Conjugated fiber |
JPH01204617A (ja) * | 1988-02-09 | 1989-08-17 | Chisso Corp | 敷物 |
GB8828669D0 (en) * | 1988-12-08 | 1989-01-11 | Lilly Industries Ltd | Organic compounds |
KR20000008130A (ko) * | 1998-07-10 | 2000-02-07 | 조정래 | 폴리에스터계 탄성사용 공중합물의 제조방법 |
WO2012094618A1 (en) | 2011-01-07 | 2012-07-12 | Corcept Therapeutics, Inc. | Combination steroid and glucocorticoid receptor antagonist therapy |
WO2013130420A1 (en) * | 2012-02-27 | 2013-09-06 | Corcept Therapeutics, Inc. | Phenyl heterocycloalkyl glucocorticoid receptor modulators |
US8859774B2 (en) | 2012-05-25 | 2014-10-14 | Corcept Therapeutics, Inc. | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
PL3848027T3 (pl) | 2013-11-25 | 2023-07-24 | Corcept Therapeutics Incorporated | Skondensowane oktahydrozwiązki azadekaliny jako modulatory receptora glukokortykoidowego |
AU2018244928B2 (en) | 2017-03-31 | 2023-10-19 | Corcept Therapeutics, Inc. | Glucocorticoid receptor modulators to treat cervical cancer |
US11234971B2 (en) | 2018-12-19 | 2022-02-01 | Corcept Therapeutics Incorporated | Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent |
WO2020132046A1 (en) | 2018-12-19 | 2020-06-25 | Corcept Therapeutics Incorporated | Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent |
WO2020132023A1 (en) | 2018-12-19 | 2020-06-25 | Corcept Therapeutics Incorporated | Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound |
BR112021015129A2 (pt) | 2019-02-22 | 2021-09-28 | Corcept Therapeutics Incorporated | Método para tratar um paciente que sofre de hipercortisolemia e um sintoma ou comorbidade da mesma |
EP4072556A4 (en) | 2019-12-11 | 2024-01-03 | Corcept Therapeutics Incorporated | METHOD FOR TREATING ANTIPSYCHOTIC-INDUCED WEIGHT GAIN WITH MIRICORILANT |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4198415A (en) * | 1979-01-22 | 1980-04-15 | Eli Lilly And Company | Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines |
US4230861A (en) * | 1979-01-22 | 1980-10-28 | Eli Lilly And Company | 1-And/or 7-substituted-6-hydroxy (or oxo)-3-decahydroquinoline carboxylic acids |
SU776048A1 (ru) * | 1979-06-05 | 1983-09-23 | Институт Бисорганической Химии Ан Бсср | Производные 8-аза-16-оксагона-17-онов, про вл ющие противовоспалительную,мембраностабилизирующую и антифибринолитическую активность,и способ их получени |
US4252945A (en) * | 1979-07-11 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Process for preparing pyrazolo[1,5-c]-quinazoline derivatives and novel intermediates |
US4367231A (en) * | 1979-09-14 | 1983-01-04 | Eli Lilly And Company | Method of using octahydro pyrazolo[3,4-g]quinolines |
ES8504174A1 (es) * | 1982-11-03 | 1985-04-16 | Lilly Co Eli | Un procedimiento para la preparacion de derivados de pirazolo-quinolinas. |
-
1984
- 1984-08-20 IL IL72729A patent/IL72729A/xx unknown
- 1984-08-20 CA CA000461330A patent/CA1270488A/en not_active Expired - Lifetime
- 1984-08-21 EP EP84305685A patent/EP0145121B1/en not_active Expired - Lifetime
- 1984-08-21 DE DE8484305685T patent/DE3484925D1/de not_active Expired - Lifetime
- 1984-08-21 GB GB08421159A patent/GB2146984B/en not_active Expired
- 1984-08-22 HU HU843161A patent/HU199836B/hu not_active IP Right Cessation
- 1984-08-22 DK DK400884A patent/DK400884A/da not_active Application Discontinuation
- 1984-08-23 GR GR80200A patent/GR80200B/el unknown
- 1984-08-24 KR KR1019840005148A patent/KR870001159B1/ko not_active IP Right Cessation
- 1984-08-24 JP JP59177382A patent/JPS6110583A/ja active Granted
-
1992
- 1992-09-16 JP JP4246440A patent/JPH0660183B2/ja not_active Expired - Lifetime
- 1992-09-16 JP JP4246442A patent/JPH0625251A/ja active Pending
- 1992-09-16 JP JP4246412A patent/JPH05194511A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
GB2146984A (en) | 1985-05-01 |
HU199836B (en) | 1990-03-28 |
GR80200B (en) | 1985-01-02 |
KR870001159B1 (ko) | 1987-06-13 |
GB8421159D0 (en) | 1984-09-26 |
EP0145121A3 (en) | 1988-04-27 |
JPH05194511A (ja) | 1993-08-03 |
EP0145121B1 (en) | 1991-08-14 |
CA1270488A (en) | 1990-06-19 |
DK400884D0 (da) | 1984-08-22 |
GB2146984B (en) | 1987-04-08 |
DE3484925D1 (de) | 1991-09-19 |
JPH0568475B2 (ko) | 1993-09-29 |
KR850002480A (ko) | 1985-05-13 |
JPH0660183B2 (ja) | 1994-08-10 |
JPH05194527A (ja) | 1993-08-03 |
EP0145121A2 (en) | 1985-06-19 |
IL72729A (en) | 1988-02-29 |
JPS6110583A (ja) | 1986-01-18 |
IL72729A0 (en) | 1984-11-30 |
JPH0625251A (ja) | 1994-02-01 |
HUT34750A (en) | 1985-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK164684D0 (da) | 4-substituerede-2-azetidinon-forbindelser,fremgangsmaade til fremstilling heraf og mellemprodukter til brug herved | |
DK400884A (da) | Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden | |
NO854826L (no) | Fremgangsmaate og apparat for broennboring. | |
DK445884D0 (da) | Fremgangsmaade til fremstilling af 1,4-dialkyl-3-methyl-4-(3-substitueret phenyl)-piperidiner og mellemprodukt til brug ved fremgangsmaaden | |
DK137083D0 (da) | Fremgangsmade til fremstilling af 26,26,26,27,27,27-hexafluorlalfa,25-dihydroxycholecalciferol og mellemprodukter til brug herved | |
DK321382A (da) | Lineaere basiske polymerisater og fremgangsmaade til fremstilling heraf | |
DK178084D0 (da) | 1,3-dihydro-6-methyl-7-hydrosyfuro-(3,4-c)-pyridinderivater og fremgangsmade til fremstilling deraf | |
DK385884A (da) | 2,6-substituerede 3,5-pyridin-dicarboxylsyre-derivater og fremgangsmaade til fremstilling heraf | |
DK172485D0 (da) | 23,23-difluor-1,25-dihydroxycholecalciferol og derivater deraf, fremgangsmaade til fremstilling af disse og mellemprodukter til brug herved | |
DK32684D0 (da) | Fremgangsmade til fremstilling af 26,26,26,27,27,27-hexafluorlalfa,25-dihydroxycholesterol og mellemprodukter til brug herfor | |
DK511884D0 (da) | Leukotrienantagonister og fremgangsmaade til fremstilling deraf | |
NO864411L (no) | Fremgangsmaate og innretning for kontinuerlig strenggrafittering av karbon-formlegemer. | |
DK416888D0 (da) | Cephalosporinforbindelser, krystallinske derivater deraf, mellemprodukter til brug ved fremstilling af cephalosporinforbindelser og fremgangsmaader til fremstilling af cephalosporinforbindelser | |
DK165952C (da) | 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf | |
NO812493L (no) | Metode for aa aapne, sammenfolde og rotere stive baatseil | |
DK406484D0 (da) | 16-flour-16,17-didehydroprostanoider samt fremgangsmaade til og mellemprodukter ved fremstilling heraf | |
IS2902A7 (is) | Aðferð til framleiðslu á 1,8-dihydroxy-10-acyl-9-anthrones, sérstaklega til meðferðar á psoriasis | |
DK52885A (da) | 1,3,2-dioxaborinan-forbindelser og fremgangsmaade til fremstilling heraf | |
DK449388A (da) | Disubstituerede tetrazol-forbindelser med leukotrien-antagonistvirkning, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden | |
NO159764C (no) | Fremgangsmaate og anordning ved fremstilling av pariserpoteter. | |
DK127182A (da) | Fremgangsmaade til fremstilling af 1,1-dioxopenicillanoyloxymethyl-6-(2-phenylacetamido)penicillanater og mellemprodukter herved | |
DK537681A (da) | 2,3-dihydropyraner og fremgangsmaade til fremstilling heraf | |
DK400984A (da) | Pyrimido(4-5-g)quinolin-derivater, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden | |
NO943548D0 (no) | Fremgangsmåte og mellomprodukter for fremstilling av 2-substituerte benzaldehyder | |
NO166355C (no) | Fremgangsmaate og anordning for stoeping av legeringer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ATS | Application withdrawn |